The microbial contaminant risk in Camber’s atovaquone oral suspension, USP 750 milligrams per 5 milliliters, can lead to “life-threatening infections such as endocarditis and necrotizing soft tissue infections,” the FDA said. No adverse reactions have been reported as of March 31.
The contaminant usually causes food poisoning, according to Cleveland Clinic.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
